79069-15-1,MFCD00235945
Catalog No.:AA008MZG

79069-15-1 | N-Boc-(S)-2-amino-3-benzyloxy-1-propanol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
97%
in stock  
$67.00   $47.00
- +
5g
≥97%
in stock  
$91.00   $64.00
- +
10g
≥97%
in stock  
$149.00   $105.00
- +
100g
≥97%
in stock  
$1,053.00   $737.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA008MZG
Chemical Name:
N-Boc-(S)-2-amino-3-benzyloxy-1-propanol
CAS Number:
79069-15-1
Molecular Formula:
C15H23NO4
Molecular Weight:
281.3474
MDL Number:
MFCD00235945
SMILES:
OC[C@H](NC(=O)OC(C)(C)C)COCc1ccccc1
Properties
Computed Properties
 
Complexity:
282  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
8  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.7  

Upstream Synthesis Route

[1]JournaloftheAmericanChemicalSociety,2017,vol.139,#19,p.6726-6735

[2]TetrahedronLetters,1995,vol.36,#8,p.1223-1226

[3]JournalofOrganicChemistry,1981,vol.46,#23,p.4799-4800

[4]BioorganicandMedicinalChemistryLetters,1997,vol.7,#9,p.1119-1122

[5]JournalofOrganicChemistry,1981,vol.46,#23,p.4797-4798

[6]TetrahedronLetters,1993,vol.34,#41,p.6513-6516

[7]JournalofOrganicChemistry,1996,vol.61,#20,p.6994-6996

[8]BioorganicandMedicinalChemistryLetters,1996,vol.6,#15,p.1799-1804

[9]BioorganicandMedicinalChemistryLetters,2006,vol.16,#6,p.1486-1490

[10]SyntheticCommunications,1996,vol.26,#13,p.2511-2522

[11]Synthesis,1990,p.299-301

[12]Patent:WO2011/69149,2011,A2,.Locationinpatent:Page/Pagecolumn26

[13]BioorganicandMedicinalChemistry,2012,vol.20,#2,p.702-713

[14]TetrahedronLetters,2012,vol.53,#26,p.3225-3229

[15]TetrahedronLetters,2012,vol.53,#32,p.4216-4220

[16]Synlett,2013,vol.24,#6,p.747-751

[1]SyntheticCommunications,1996,vol.26,#13,p.2511-2522

[2]NucleosidesandNucleotides,1999,vol.18,#8,p.1845-1861

[3]BioorganicandMedicinalChemistry,2012,vol.20,#2,p.702-713

[1]Patent:EP1481976,2004,A1,.Locationinpatent:Page226

[1]Patent:EP1679296,2006,A1,.Locationinpatent:Page/Pagecolumn29

[1]Patent:US2012/28995,2012,A1,.Locationinpatent:Page/Pagecolumn70

Downstream Synthesis Route

[1]TetrahedronLetters,1989,vol.30,p.5045-5048

[1]JournaloftheAmericanChemicalSociety,2017,vol.139,p.6726-6735

[2]TetrahedronLetters,1995,vol.36,p.1223-1226

[3]JournalofOrganicChemistry,1981,vol.46,p.4799-4800

[4]BioorganicandMedicinalChemistryLetters,1997,vol.7,p.1119-1122

[5]JournalofOrganicChemistry,1981,vol.46,p.4797-4798

[6]TetrahedronLetters,1993,vol.34,p.6513-6516

[7]JournalofOrganicChemistry,1996,vol.61,p.6994-6996

[8]BioorganicandMedicinalChemistryLetters,1996,vol.6,p.1799-1804

[9]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.1486-1490

[10]SyntheticCommunications,1996,vol.26,p.2511-2522

[11]Synthesis,1990,p.299-301

[12]Patent:WO2011/69149,2011,A2.Locationinpatent:Page/Pagecolumn26

[13]BioorganicandMedicinalChemistry,2012,vol.20,p.702-713

[14]TetrahedronLetters,2012,vol.53,p.3225-3229

[15]TetrahedronLetters,2012,vol.53,p.4216-4220

[16]Synlett,2013,vol.24,p.747-751

[17]JournalofOrganicChemistry,2018,vol.83,p.11777-11793

[1]Patent:WO2011/69149,2011,A2.Locationinpatent:Page/Pagecolumn26

[2]JournaloftheAmericanChemicalSociety,2017,vol.139,p.6726-6735

[3]Bioorganicandmedicinalchemistryletters,2004,vol.14,p.275-278

[4]JournalofOrganicChemistry,1981,vol.46,p.4797-4798

[5]BioorganicandMedicinalChemistryLetters,2003,vol.13,p.375-377

[6]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.1486-1490

[7]TetrahedronLetters,2012,vol.53,p.4216-4220

[8]Synlett,2013,vol.24,p.747-751

[9]JournalofOrganicChemistry,2018,vol.83,p.11777-11793

[1]TetrahedronLetters,1993,vol.34,p.6513-6516

(C5H9O2)(NHCHCOO)(CH2OC7H7)(CO2C2H5) 
  79069-15-1 

[1]Synthesis,1990,p.299-301

[2]BioorganicandMedicinalChemistryLetters,2003,vol.13,p.375-377

[3]Synlett,2013,vol.24,p.747-751

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Historical Records
Tags:79069-15-1 Molecular Formula|79069-15-1 MDL|79069-15-1 SMILES|79069-15-1 N-Boc-(S)-2-amino-3-benzyloxy-1-propanol
Catalog No.: AA008MZG
79069-15-1,MFCD00235945
79069-15-1 | N-Boc-(S)-2-amino-3-benzyloxy-1-propanol
Pack Size: 1g
Purity: 97%
in stock
$67.00 $47.00
Pack Size: 5g
Purity: ≥97%
in stock
$91.00 $64.00
Pack Size: 10g
Purity: ≥97%
in stock
$149.00 $105.00
Pack Size: 100g
Purity: ≥97%
in stock
$1,053.00 $737.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA008MZG
Chemical Name: N-Boc-(S)-2-amino-3-benzyloxy-1-propanol
CAS Number: 79069-15-1
Molecular Formula: C15H23NO4
Molecular Weight: 281.3474
MDL Number: MFCD00235945
SMILES: OC[C@H](NC(=O)OC(C)(C)C)COCc1ccccc1
Properties
Complexity: 282  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 20  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 8  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.7  
Upstream Synthesis Route
23680-31-1    79069-15-1 

[1]JournaloftheAmericanChemicalSociety,2017,vol.139,#19,p.6726-6735

[2]TetrahedronLetters,1995,vol.36,#8,p.1223-1226

[3]JournalofOrganicChemistry,1981,vol.46,#23,p.4799-4800

[4]BioorganicandMedicinalChemistryLetters,1997,vol.7,#9,p.1119-1122

[5]JournalofOrganicChemistry,1981,vol.46,#23,p.4797-4798

[6]TetrahedronLetters,1993,vol.34,#41,p.6513-6516

[7]JournalofOrganicChemistry,1996,vol.61,#20,p.6994-6996

[8]BioorganicandMedicinalChemistryLetters,1996,vol.6,#15,p.1799-1804

[9]BioorganicandMedicinalChemistryLetters,2006,vol.16,#6,p.1486-1490

[10]SyntheticCommunications,1996,vol.26,#13,p.2511-2522

[11]Synthesis,1990,p.299-301

[12]Patent:WO2011/69149,2011,A2,.Locationinpatent:Page/Pagecolumn26

[13]BioorganicandMedicinalChemistry,2012,vol.20,#2,p.702-713

[14]TetrahedronLetters,2012,vol.53,#26,p.3225-3229

[15]TetrahedronLetters,2012,vol.53,#32,p.4216-4220

[16]Synlett,2013,vol.24,#6,p.747-751

66866-45-3    79069-15-1 

[1]SyntheticCommunications,1996,vol.26,#13,p.2511-2522

[2]NucleosidesandNucleotides,1999,vol.18,#8,p.1845-1861

[3]BioorganicandMedicinalChemistry,2012,vol.20,#2,p.702-713

13650-73-2    79069-15-1 

[1]Patent:EP1481976,2004,A1,.Locationinpatent:Page226

23680-31-1    541-41-3    79069-15-1 

[1]Patent:EP1679296,2006,A1,.Locationinpatent:Page/Pagecolumn29

24424-99-5    10433-52-0    79069-15-1 

[1]Patent:US2012/28995,2012,A1,.Locationinpatent:Page/Pagecolumn70

Downstream Synthesis Route
108-30-5    79069-15-1    127559-37-9 

[1]TetrahedronLetters,1989,vol.30,p.5045-5048

23680-31-1    79069-15-1 

[1]JournaloftheAmericanChemicalSociety,2017,vol.139,p.6726-6735

[2]TetrahedronLetters,1995,vol.36,p.1223-1226

[3]JournalofOrganicChemistry,1981,vol.46,p.4799-4800

[4]BioorganicandMedicinalChemistryLetters,1997,vol.7,p.1119-1122

[5]JournalofOrganicChemistry,1981,vol.46,p.4797-4798

[6]TetrahedronLetters,1993,vol.34,p.6513-6516

[7]JournalofOrganicChemistry,1996,vol.61,p.6994-6996

[8]BioorganicandMedicinalChemistryLetters,1996,vol.6,p.1799-1804

[9]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.1486-1490

[10]SyntheticCommunications,1996,vol.26,p.2511-2522

[11]Synthesis,1990,p.299-301

[12]Patent:WO2011/69149,2011,A2.Locationinpatent:Page/Pagecolumn26

[13]BioorganicandMedicinalChemistry,2012,vol.20,p.702-713

[14]TetrahedronLetters,2012,vol.53,p.3225-3229

[15]TetrahedronLetters,2012,vol.53,p.4216-4220

[16]Synlett,2013,vol.24,p.747-751

[17]JournalofOrganicChemistry,2018,vol.83,p.11777-11793

79069-15-1    79069-54-8 

[1]Patent:WO2011/69149,2011,A2.Locationinpatent:Page/Pagecolumn26

[2]JournaloftheAmericanChemicalSociety,2017,vol.139,p.6726-6735

[3]Bioorganicandmedicinalchemistryletters,2004,vol.14,p.275-278

[4]JournalofOrganicChemistry,1981,vol.46,p.4797-4798

[5]BioorganicandMedicinalChemistryLetters,2003,vol.13,p.375-377

[6]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.1486-1490

[7]TetrahedronLetters,2012,vol.53,p.4216-4220

[8]Synlett,2013,vol.24,p.747-751

[9]JournalofOrganicChemistry,2018,vol.83,p.11777-11793

79069-15-1    153782-93-5 

[1]TetrahedronLetters,1993,vol.34,p.6513-6516

(C5H9O2)(NHCHCOO)(CH2OC7H7)(CO2C2H5) 
  79069-15-1 

[1]Synthesis,1990,p.299-301

[2]BioorganicandMedicinalChemistryLetters,2003,vol.13,p.375-377

[3]Synlett,2013,vol.24,p.747-751

Building Blocks More >
80074-34-6
80074-34-6
Methyl 2-ethoxy-5-nitrobenzoate
AA008NM3 | MFCD12173002
777853-12-0
777853-12-0
4-(2-Chlorophenyl)-2-methylthiazole
AA008OEC | MFCD08832472
74128-84-0
74128-84-0
2-bromo-1-iodo-3-methoxybenzene
AA008OZ0 | MFCD18391616
76686-84-5
76686-84-5
3-(1,2,4-Triazol-1-yl)propanoic acid
AA008PK5 | MFCD02932735
73686-77-8
73686-77-8
4-(PROPYLAMINO)BENZOIC ACID
AA008Q9J | MFCD02856235
121082-99-3
121082-99-3
1-(3,4,5-Trimethoxyphenyl)ethanamine hydrochloride
AA008QX0 | MFCD02656660
108605-62-5
108605-62-5
Teriflunomide(Random Configuration)
AA008R6N | MFCD00910058
120068-36-2
120068-36-2
FIPRONIL-SULFONE
AA008RI9 | MFCD01938707
107955-83-9
107955-83-9
6-Bromo-2,5-dioxo-1,2,5,6,7,8-hexahydroquinoline-3-carbonitrile
AA008ROG | MFCD00829040
1131-40-4
1131-40-4
1-Bromo-2,4,6-trimethoxybenzene
AA008RXZ | MFCD00040757
Submit
© 2017 AA BLOCKS, INC. All rights reserved.